Asia
Wuhan Hiteck Biological Pharma Gets China Approval for Antifungal Injection
China's drug regulator approved Wuhan Hiteck Biological Pharma's (SHE:300683) registration for its isavuconazonium sulfate injection, according to a Monday disclosure to the Shenzhen bourse.Shares closed 2% on Tuesday afternoon.The drug treats invasive aspergillosis and invasive mucormycosis, two life-threatening fungal infections.
SHE:300683
